Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Head and Neck: a Prospective, Single-arm,Phase II Study (NCT05586100) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2022-10-13 |
Track Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.